Literature DB >> 15221963

Mutation analysis of the RECQL4 gene in sporadic osteosarcomas.

Koichi Nishijo1, Tomitaka Nakayama, Tomoki Aoyama, Takeshi Okamoto, Tatsuya Ishibe, Ko Yasura, Yasuko Shima, Kotaro R Shibata, Tadao Tsuboyama, Takashi Nakamura, Junya Toguchida.   

Abstract

Osteosarcoma (OS) is the most prevalent malignant tumor among cases of Rothmund-Thomson syndrome (RTS) with germline mutations of the RECQL4 gene, a member of the RecQ helicase family. We investigated the involvement of the RECQL4 gene in the development of OS unrelated to RTS. RECQL4 mRNA was detected in 9 of 9 OS cell lines by Northern blotting and 26 of 26 OS tumors by RT-PCR. Direct sequencing of the entire coding region along with flanking splice junctions and 13 small (< 100 bp) introns in 71 OS tumors revealed 2 sites with a single-base change causing an amino acid change (G1814A for R355Q and C2474T for P441S) and one site with a 6 bp inframe deletion (4837-42delTGCACC for CT857-8del). Identical genotypes were found in corresponding normal tissues in all cases, and the frequency of each allele was not significantly different between OS and control populations. Our data indicate that the RECQL4 gene is not a frequent target for somatic mutations in sporadic OS unrelated to RTS. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221963     DOI: 10.1002/ijc.20269

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Biomarkers in Osteosarcoma.

Authors:  Colin Kong; Marc F Hansen
Journal:  Expert Opin Med Diagn       Date:  2009-01-01

Review 2.  Rothmund-Thomson syndrome.

Authors:  Lidia Larizza; Gaia Roversi; Ludovica Volpi
Journal:  Orphanet J Rare Dis       Date:  2010-01-29       Impact factor: 4.123

3.  Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma.

Authors:  Georges Maire; Maisa Yoshimoto; Susan Chilton-MacNeill; Paul S Thorner; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

Review 4.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

5.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20

6.  Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.

Authors:  Paula Paulo; Sofia Maia; Carla Pinto; Pedro Pinto; Augusta Monteiro; Ana Peixoto; Manuel R Teixeira
Journal:  PLoS Genet       Date:  2018-04-16       Impact factor: 5.917

7.  Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma.

Authors:  Kim E Nichols; Chimene A Kesserwan; Jamie L Maciaszek; Ninad Oak; Wenan Chen; Kayla V Hamilton; Rose B McGee; Regina Nuccio; Roya Mostafavi; Stacy Hines-Dowell; Lynn Harrison; Leslie Taylor; Elsie L Gerhardt; Annastasia Ouma; Michael N Edmonson; Aman Patel; Joy Nakitandwe; Alberto S Pappo; Elizabeth M Azzato; Sheila A Shurtleff; David W Ellison; James R Downing; Melissa M Hudson; Leslie L Robison; Victor Santana; Scott Newman; Jinghui Zhang; Zhaoming Wang; Gang Wu
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-10-23

8.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.